www.cms.gov Open in urlscan Pro
2a02:26f0:1700:384::28a  Public Scan

Submitted URL: https://lnks.gd/l/eyJhbGciOiJIUzI1NiJ9.eyJidWxsZXRpbl9saW5rX2lkIjoxMDEsInVyaSI6ImJwMjpjbGljayIsImJ1bGxldGluX2lkI...
Effective URL: https://www.cms.gov/outreach-and-educationoutreachffsprovpartprogprovider-partnership-email-archive/2022-05-26-mlnc
Submission: On May 26 via api from US — Scanned from DE

Form analysis 2 forms found in the DOM

GET /search/cms

<form action="/search/cms" method="get" id="search-block-form" accept-charset="UTF-8" class="search-form search-block-form">
  <div class="js-form-item form-item js-form-type-search form-type-search js-form-item-keys form-item-keys form-no-label">
    <label for="edit-keys--2" class="visually-hidden">Search</label>
    <input title="Enter the terms you wish to search for." placeholder="Search CMS" aria-label="Search CMS" data-drupal-selector="edit-keys" type="search" id="edit-keys--2" name="keys" value="" size="15" maxlength="128" class="form-search">
  </div>
  <div data-drupal-selector="edit-actions" class="form-actions js-form-wrapper form-wrapper" id="edit-actions--2"><input data-drupal-selector="edit-submit" type="submit" id="edit-submit--3" value="Search" class="button js-form-submit form-submit">
  </div>
</form>

POST https://public.govdelivery.com/accounts/USCMS/subscribers/qualify

<form accept-charset="UTF-8" action="https://public.govdelivery.com/accounts/USCMS/subscribers/qualify" id="email-footer-form" method="post" data-drupal-form-fields="email-footer-input,email-submit">
  <div aria-label="Enter your email address for email updates" id="email-form"><input aria-label="Enter your email address:" name="email" placeholder="type your email here" type="text">
    <input id="email-submit" name="email-footer-submit" type="submit" value="Submit">
  </div>
</form>

Text Content

Skip to main content

An official website of the United States government

Here’s how you know

Here’s how you know

The .gov means it’s official.

Federal government websites often end in .gov or .mil. Before sharing sensitive
information, make sure you’re on a federal government site.

The site is secure.

The https:// ensures that you are connecting to the official website and that
any information you provide is encrypted and transmitted securely.


HEADER

 * Home
 * About CMS
 * Newsroom
 * Archive
 * Help
 * Print





Search



SITE

 * Medicare
 * Medicaid/CHIP
 * Medicare-Medicaid Coordination
 * Private Insurance
 * Innovation Center
 * Regulations & Guidance
 * Research, Statistics, Data & Systems
 * Outreach & Education


BREADCRUMB

 * Back to MLN Connects® Newsletter


2022-05-26-MLNC



Date
2022-05-26
Subject
Biosimilars: Interchangeable Products May Increase Patient Access

Thursday, May 26, 2022

News

 * COVID-19: New Administration Code for Pfizer Pediatric Vaccine Booster Dose
 * Biosimilars: Interchangeable Products May Increase Patient Access
 * Critical Care Evaluation & Management Services: Comparative Billing Report in
   May

Compliance

 * Surgical Dressings: Medicare Requirements

Publications

 * Screening Pap Tests & Pelvic Exams — Revised

 


NEWS


COVID-19: NEW ADMINISTRATION CODE FOR PFIZER PEDIATRIC VACCINE BOOSTER DOSE

On May 17, 2022, the FDA amended the Pfizer-BioNTech COVID-19 vaccine emergency
use authorization (PDF) to authorize the use of a single booster pediatric dose
(orange cap) for all patients 5–11 years old. CMS issued a new code, effective
May 17, 2022, for the vaccine administration:

Code: 0074A

 * Long descriptor: Immunization administration by intramuscular injection of
   severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus
   disease [COVID-19]) vaccine, mRNALNP, spike protein, preservative free, 10
   mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation
 * Short descriptor: ADM SARSCV2 10MCG TRS-SUCR B

For more information, visit the COVID-19 Provider Toolkit, and get the most
current list of billing codes, payment allowances, and effective dates. (Note:
you may need to refresh your browser if you recently visited these webpages).

 


BIOSIMILARS: INTERCHANGEABLE PRODUCTS MAY INCREASE PATIENT ACCESS

Depending on state pharmacy laws, you may substitute an interchangeable
biosimilar product at the pharmacy, much like substituting a generic for a
brand-name drug. This helps increase patient access to biologics and may reduce
patient costs. Learn more about Interchangeable Biological Products from the
FDA. Bookmark FDA’s Biosimilars webpage and materials for health care providers
and patients.

Additional FDA resources you may find helpful:

 * Overview of Biosimilar Products
 * Biosimilar Regulatory Review and Approval (PDF)

 


CRITICAL CARE EVALUATION & MANAGEMENT SERVICES: COMPARATIVE BILLING REPORT IN
MAY

In late May, CMS will issue a Comparative Billing Report (CBR) on Medicare Part
B claims for critical care evaluation and management services. Use the
data-driven report to compare your billing practices with those of peers in your
state and across the nation.

CBRs aren’t publicly available. Look for an email from
cbrpepper.noreply@religroupinc.com to access your report. Update your email
address in PECOS to make sure you get it.

More Information:

 * View a webinar recording
 * Visit the CBR website
 * Register for a live webinar on June 8 from 3–4 pm ET

 


COMPLIANCE


SURGICAL DRESSINGS: MEDICARE REQUIREMENTS

Medicare covers primary or secondary surgical dressings:

 * When used to protect or treat a wound
 * If needed after you debride a wound

You must:

 * Include clinical information in patients’ medical records that demonstrates a
   reasonable and necessary need for the type and quantity of surgical dressings
 * Evaluate the wound monthly and update the record, unless you document why you
   can't do a monthly evaluation and how you're monitoring the patient's ongoing
   use of dressings

For more information, see the Surgical Dressings – Policy Article.

 


PUBLICATIONS


SCREENING PAP TESTS & PELVIC EXAMS — REVISED

Learn about 3 new ICD-10 diagnosis codes for these screenings (PDF):

 * Z92.850 – Personal history of Chimeric Antigen Receptor T-cell therapy
 * Z92.858 – Personal history of other cellular therapy
 * Z92.86 – Personal history of gene therapy

 

--------------------------------------------------------------------------------

Subscribe to the MLN Connects® newsletter. You can read previous issues in the
archive.

This newsletter is current as of the issue date. View the complete disclaimer.

The Medicare Learning Network®, MLN Connects®, and MLN Matters® are registered
trademarks of the U.S. Department of Health and Human Services (HHS).



 

Home
A federal government website managed and paid for by the U.S. Centers for
Medicare & Medicaid Services. 7500 Security Boulevard, Baltimore, MD 21244


CMS & HHS WEBSITES

 * Medicare.gov
 * Medicaid.gov
 * InsureKidsNow.gov
 * HealthCare.gov
 * HHS.gov/Open


TOOLS

 * Acronyms
 * Archive
 * Contacts
 * Glossary


HELPFUL LINKS

 * Web Policies & Important Links
 * Careers
 * For Developers
 * Plain Language
 * Privacy Policy
 * Privacy Settings
 * Freedom of Information Act
 * No Fear Act
 * Nondiscrimination/Accessibility
 * HHS.gov
 * Inspector General
 * USA.gov
 * Help with file formats & plug-ins


RECEIVE EMAIL UPDATES


 


CONNECT WITH CMS

 * Twitter link
 * Youtube link
 * Facebook link
 * Linkedin link
 * RSS Feed link



Feedback